DopplerBio
ImmuneID
Newleos
Newleos Therapeutics is a clinical-stage biotechnology company co-founded by Longwood Fund and seasoned leaders in CNS drug development. Newleos’ pipeline was licensed from Roche and focuses on innovative neuropsychiatric mechanisms of action that aim to reduce side effects and improve outcomes compared to the current standard of care. Our clinical-stage, oral small molecules target GABAA-γ1, […]
Weaver
Solu Therapeutics
Solu Therapeutics was established in May 2023 following the granting of an exclusive license to the CyTAC platform from GSK. We are a clinical-stage company advancing our lead program through Phase 1 trials in chronic myelomonocytic leukemia, with additional CyTAC and TicTAC programs rapidly progressing toward development candidate status.
DEMBio
DEM Biopharma is a pre-IND stage biopharmaceutical company dedicated to discovering novel therapeutic targets for solid tumors. Our innovative platform enables us to identify unique strategies to attack tumor cells and the tumor microenvironment (TME). We have an Experienced Leadership and Operating team, World-Class Scientific Founders and Advisors, and outstanding Investor Syndicate.
Carbon Biosciences
Expanding the therapeutic potential of gene therapy Carbon Biosciences is expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues and carry a larger cargo with minimal neutralizing immunity and the potential to re-dose. Founded by Longwood Fund and […]
Photys
Photys Therapeutics is a proximity-based therapeutics company with expertise across bifunctional platforms. This includes PROTACs, its proprietary PHICS™ (PHosphorylation Inducing Chimeric Small molecules) platform, and its proprietary tPRIME™ (targeted-PRoximity Induced Modulators of Expression) platform. Photys’ various approaches allows selective modulation of a target protein to achieve a desired alteration of the target’s biologic function, which […]
Tome
Be Biopharma
Be Bio is pioneering Engineered B cell Medicines (BCMs) to dramatically improve the lives of patients who are living with genetic disease, cancer, and other serious conditions. The B cell is a powerful cell that produces thousands of proteins per cell per second at constant levels over decades. Precision engineering can now be used to […]